5 completed, 2 not yet recruiting, 2 recruiting, 1 terminated. 3 Not applicable, 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 2, Recruiting 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Testis Cancer: new trials by email Literature Review of Testis Cancer trials Research Report on Testis Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Helping Young People With Testicular Cancer Using Virtual and Extended Reality Digital tool using extended reality - Testicular Cancer, Testis Cancer | Not applicable | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 245 | 2027-01-04 | 2026-05-06 |
| Virtual Testis Cancer Lay Support and Survivorship Aim 2 Virtual support, Patient educational material - Testicular Cancer, Testis Cancer | Not applicable | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 360 | 2026-09-01 | 2026-08-18 |
| Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3) Pub2Post - Prostate Cancer (Adenocarcinoma), Bladder Cancer | Phase 2 | Completed | University of Southern California | 120 | 2025-01-16 | 2026-05-06 |
| miRNA to Guide Appropriate Intervention of Small Testis Masses Testis Cancer | Recruiting | University Health Network, Toronto | 100 | 2023-07-12 | 2026-10-01 | |
| The Man Van Project MV-POCT Sub-study, Main Man Van Group Sub-study (MV-Eco), MV-QualQ Sub-study - Prostate Cancer, Urologic Cancer | Not applicable | Recruiting | Royal Marsden NHS Foundation Trust | 4000 | 2022-04-13 | 2024-05-01 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment Biomarker Testing (L), Systemic Treatment (T), Patient Reported Outcomes (P) - Adenocarcinoma, Adenocystic Carcinoma | Completed | Taproot Health | 167 | 2021-05-05 | 2024-12-18 | |
| Mental Health of Men Before and After Testicular Cancer Treatment Testis Cancer, Cognitive Impairment | Completed | University of Aarhus | 29 | 2019-03-25 | 2024-05-16 | |
| A Biobehavioral Intervention for Young Men With Testicular Cancer Goal-Focused Emotion Regulation Therapy (GET), Individual Supportive Psychotherapy (ISP) - Testis Cancer | Phase 2 | Unknown | University of California, Irvine | 100 | 2018-11-01 | 2020-12-19 |
| Role of Axumin PET Scan in Germ Cell Tumor Axumin PET scan - Testis Cancer, Germ Cell Tumor | Completed | University of Texas Southwestern Medical Center | 10 | 2018-03-01 | 2025-08-11 | |
| Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors Brentuximab Vedotin - Germ Cell Tumors, Testis Cancer | Phase 2 | Terminated | Nabil Adra | 18 | 2016-03-09 | 2019-12-10 |
| Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors Guadecitabine (SGI-110) - Germ Cell Tumor, Testis Cancer | Phase 1 | Completed | Nasser Hanna | 14 | 2015-04-27 | 2020-09-23 |
Testicular Neoplasms (11) · Kidney Neoplasms (3) · Neoplasms, Germ Cell and Embryonal (3) · Prostatic Neoplasms (3) · Urinary Bladder Neoplasms (3) · Adenocarcinoma (2) · Testicular Germ Cell Tumor (2) · Adrenal Gland Neoplasms (1) · Alcoholism (1) · Anus Neoplasms (1) · Anxiety Disorders (1) · Appendiceal Neoplasms (1) · Astrocytoma (1) · Bile Duct Neoplasms (1) · Bone Neoplasms (1)
Endocrine Gland Neoplasms (11) · Endocrine System Diseases (11) · Genital Diseases (11) · Genital Diseases, Male (11) · Genital Neoplasms, Male (11) · Gonadal Disorders (11) · Male Urogenital Diseases (11) · Neoplasms by Site (11) · Urogenital Diseases (11) · Urogenital Neoplasms (11) · Neoplasms (10) · Testicular Diseases (10) · Neoplasms by Histologic Type (5) · Behavior (3) · Female Urogenital Diseases (3)
Biological Therapy (1) · Brentuximab Vedotin (1) · Drug Therapy (1) · Immunotherapy (1) · Molecular Diagnostic Techniques (1) · Patient Reported Outcome Measures (1) · Quality of Life (1) · guadecitabine (1)
Gustave Roussy, Cancer Campus, Grand Paris (1) · Nabil Adra (1) · Nasser Hanna (1) · Royal Marsden NHS Foundation Trust (1) · Taproot Health (1) · UNC Lineberger Comprehensive Cancer Center (1) · University Health Network, Toronto (1) · University of Aarhus (1) · University of California, Irvine (1) · University of Southern California (1) · University of Texas Southwestern Medical Center (1)
United States (7) · Canada (1) · Denmark (1) · United Kingdom (1)
Anna Patrikidou (1) · Costantine Albany, MD (1) · Hung-Jui Tan, MD (1) · Jennifer Johnson, MD, PhD (1) · Nasser Hanna, MD (1) · Nicholas D James, MBBS, FRCP, FRCR, PhD (1) · Raymond Bergan, MD (1) · Razelle Kurzrock, MD (1) · Vivek Subbiah, MD (1) · Yair Lotan, MD (1)